Wikidata

(Q39395362)

English

Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis

scientific article published on April 16, 2003

In more languages

Statements

title
Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12730532
retrieved
11 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39395362&oldid=2040496433"